Salamanca woman jailed on murder, other charges
Breaking News
Salamanca woman jailed on murder, other charges
November 1, 2025
SALAMANCA — A city woman is facing murder and other felony charges after a death on River Street on Friday morning. The Salamanca Police Department re...
Home Online Features Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab
Press Releases
Akeso, Inc.  
April 25, 2025

Ivonescimab Receives NMPA Approval for First-Line Treatment of PD-L1-Positive NSCLC, Based on Breakthrough Head to Head Phase III Trial Demonstrating Superior Efficacy Over Pembrolizumab

HONG KONG, April 25, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that its globally first-in-class PD-1/VEGF bispecific antibody, ivonescimab, has received approval from

logo salamanca press

Salamanca Press

email salamanca press
Local & Social